SIMIAN VACCINE EVALUATION UNITS
$2,560,239N01FY2000AINIH
Advanced Bioscience Laboratories, Inc., Kensington MD
Investigators
Linked publications & trials
Abstract
This contract is designed to evaluate experimental HIV vaccine strategies in non-human primates before these vaccines would proceed into clinical trials. Vaccines will be tested for safety and immunogenicity. Challenge studies using Simian Immunodeficiency Virus (SIV) or chimeric HIV/(SIV (SHIV) viruses will also be performed. Vaccine strategies investigated will include nucleic acid vaccines, recombinant proteins, whole-killed and attenuated viral vaccines as well as immunologic adjuvants and antigen delivery systems.
View original record on NIH RePORTER →